First Time Loading...
N

NewAmsterdam Pharma Company NV
NASDAQ:NAMS

Watchlist Manager
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
Watchlist
Price: 19.1787 USD -0.63% Market Closed
Updated: Jun 10, 2024

NewAmsterdam Pharma Company NV
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NewAmsterdam Pharma Company NV
Net Income (Common) Peer Comparison

Comparables:
PHARM
PRQR
QURE
ARGX
MRUS

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
N
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
Net Income (Common)
-€78.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Net Income (Common)
-$10.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
8%
ProQR Therapeutics NV
NASDAQ:PRQR
Net Income (Common)
-€26.8m
CAGR 3-Years
15%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Net Income (Common)
-$296.9m
CAGR 3-Years
-29%
CAGR 5-Years
-26%
CAGR 10-Years
-22%
argenx SE
XBRU:ARGX
Net Income (Common)
-$429.3m
CAGR 3-Years
20%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Net Income (Common)
-$149.6m
CAGR 3-Years
-24%
CAGR 5-Years
-43%
CAGR 10-Years
N/A

See Also

What is NewAmsterdam Pharma Company NV's Net Income (Common)?
Net Income (Common)
-78.1m EUR

Based on the financial report for Dec 31, 2022, NewAmsterdam Pharma Company NV's Net Income (Common) amounts to -78.1m EUR.